These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16738201)

  • 1. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis.
    Agostini C; Gurrieri C
    Proc Am Thorac Soc; 2006 Jun; 3(4):357-63. PubMed ID: 16738201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances on the role of chemokines/chemokine receptors in the pathogenesis of idiopathic pulmonary fibrosis].
    Brunetti G; Pignatti P
    Recenti Prog Med; 2007 Feb; 98(2):90-6. PubMed ID: 17439069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic pulmonary fibrosis].
    Doubková M; Skhicková J
    Vnitr Lek; 2005 Dec; 51(12):1375-84. PubMed ID: 16430105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis.
    Keane MP; Arenberg DA; Lynch JP; Whyte RI; Iannettoni MD; Burdick MD; Wilke CA; Morris SB; Glass MC; DiGiovine B; Kunkel SL; Strieter RM
    J Immunol; 1997 Aug; 159(3):1437-43. PubMed ID: 9233641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine network in the pathogenesis of idiopathic pulmonary fibrosis.
    Antoniou KM; Alexandrakis MG; Siafakas NM; Bouros D
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Jun; 22(2):91-104. PubMed ID: 16053024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pulmonary fibrosis: molecular mechanisms and possible therapeutic strategies.
    van den Blink B; Jansen HM; Peppelenbosch MP
    Arch Immunol Ther Exp (Warsz); 2000; 48(6):539-45. PubMed ID: 11197609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.
    Selman M; Pardo A
    Proc Am Thorac Soc; 2006 Jun; 3(4):364-72. PubMed ID: 16738202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
    Andersson-Sjöland A; de Alba CG; Nihlberg K; Becerril C; Ramírez R; Pardo A; Westergren-Thorsson G; Selman M
    Int J Biochem Cell Biol; 2008; 40(10):2129-40. PubMed ID: 18374622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.
    Burdick MD; Murray LA; Keane MP; Xue YY; Zisman DA; Belperio JA; Strieter RM
    Am J Respir Crit Care Med; 2005 Feb; 171(3):261-8. PubMed ID: 15502109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.
    Thannickal VJ; Horowitz JC
    Proc Am Thorac Soc; 2006 Jun; 3(4):350-6. PubMed ID: 16738200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis.
    Antoniou KM; Pataka A; Bouros D; Siafakas NM
    Pulm Pharmacol Ther; 2007; 20(5):453-61. PubMed ID: 16516512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaching the degradome in idiopathic pulmonary fibrosis.
    Pardo A; Selman M; Kaminski N
    Int J Biochem Cell Biol; 2008; 40(6-7):1141-55. PubMed ID: 18207447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic pulmonary fibrosis (IPF)].
    Matsumoto A; Azuma A
    Nihon Rinsho; 2006 Jul; 64(7):1354-60. PubMed ID: 16838656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of idiopathic pulmonary fibrosis].
    Buhl R; Meier-Sydow J; Vogelmeier C
    Immun Infekt; 1995 Jun; 23(3):92-6. PubMed ID: 7615308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.
    Gharaee-Kermani M; Gyetko MR; Hu B; Phan SH
    Pharm Res; 2007 May; 24(5):819-41. PubMed ID: 17333393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Into the matrix: targeting fibroblasts in pulmonary fibrosis.
    Sivakumar P; Ntolios P; Jenkins G; Laurent G
    Curr Opin Pulm Med; 2012 Sep; 18(5):462-9. PubMed ID: 22847104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis.
    Gharaee-Kermani M; Phan SH
    Curr Pharm Des; 2005; 11(30):3943-71. PubMed ID: 16305523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis: cellular and molecular biology of the disease].
    Yoshimura K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():20-31. PubMed ID: 8007466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.
    Wuyts WA; Willems S; Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Rinaldi M; Vanhooren HM; Geudens N; Verleden SE; Demedts MG; Thomeer M; Verbeken EK; Verleden GM
    Exp Lung Res; 2010 Dec; 36(10):602-14. PubMed ID: 20874225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic pulmonary fibrosis: misunderstandings between epithelial cells and fibroblasts?
    Selman M; Pardo A
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Oct; 21(3):165-72. PubMed ID: 15554072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.